IceCure Medical initially adjourns shareholder meeting for lack of quorum
ICCM•IceCure Medical shareholders approved the proposal outlined in its proxy statement at a special general meeting on November 19, 2026.
ICCM•IceCure Medical shareholders approved the proposal outlined in its proxy statement at a special general meeting on November 19, 2026.
IceCure Medical shareholders approved the proposal outlined in the company’s proxy statement at a special general meeting on November 19, 2026.